Protalix BioTherapeutics
PLX
#8601
Rank
A$0.36 B
Marketcap
A$4.38
Share price
-5.23%
Change (1 day)
61.69%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): A$35.67 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$80.61 Million. In 2025 the company made an earning of -A$6.43 Million a decrease over its 2024 earnings that were of A$7.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$35.67 M-654.79%
2025 -A$6.43 Million-181.6%
2024 A$7.88 M-55.62%
2023 A$17.75 M-199.05%
2022 -A$17.93 Million-40.38%
2021 -A$30.08 Million-732.31%
2020 A$4.75 M-130.53%
2019 -A$15.58 Million189.85%
2018 -A$5.38 Million-95.29%
2017 -A$0.12 Billion308.12%
2016 -A$27.97 Million-32.37%
2015 -A$41.36 Million10.11%
2014 -A$37.56 Million-7.59%
2013 -A$40.64 Million
2011 -A$47.06 Million-19.39%
2010 -A$58.39 Million20.87%
2009 -A$48.3 Million32.26%
2008 -A$36.52 Million-5.46%
2007 -A$38.63 Million
2004 -A$0.26 Million12.35%
2003 -A$0.23 Million-11.1%
2002 -A$0.26 Million-57.03%
2001 -A$0.59 Million1.03%
2000 -A$0.58 Million-53.22%
1999 -A$1.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.52 B 28,094.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.30 B 3,391.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.28 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.84 B 4,852.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel